05.07.2013 Views

PDF file - Facultatea de Chimie şi Inginerie Chimică

PDF file - Facultatea de Chimie şi Inginerie Chimică

PDF file - Facultatea de Chimie şi Inginerie Chimică

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PHARMACOKINETIC INTERACTION BETWEEN IVABRADINE AND CIPROFLOXACINE …<br />

Concentration (ng/ml)<br />

14<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

Figure 2. Mean (±SD) plasma levels of ivabradine (5 mg p.o.) given alone<br />

(continuous line) or in combination with ciprofloxacin (500 mg, p.o.)<br />

after treatment with ciprofloxacin for 6 days (500 mg p.o.) (dotted line),<br />

n=18; in insert: semilogaritmic presentation.<br />

Table1. Pharmacokinetic parameters of ivabradine administered alone or<br />

after treatment with ciprofloxacin and the result of statistical t test<br />

used for comparison<br />

Pharmacokinetic Ivabradine alone Ivabradine +<br />

p* value,<br />

parameter (±SD)<br />

ciprofloxacin t-test<br />

Cmax (ng/ml) 8.52(4.37) 8.40(4.67) 0.78<br />

tmax (hr) 0.86(0.41) 1.52(0.52) * 0.0014<br />

AUC0-∞ (ng.hr/ml) 27.92(13.59) 28.15(13.74) 0.85<br />

kel (1/hr) 0.35(0.10) 0.37(0.08) 0.36<br />

ka (1/hr) 10.8(6.8) 5.27(6.71) * 0.025<br />

t½ (hr) 2.10(0.60) 1.93(0.44) 0.28<br />

* significance for p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!